Search results
Author(s):
Stephen Ralph Large
,
David Phillip Jenkins
Added:
3 years ago
There is emerging clarity in the management of pulmonary embolism (PE) as information has been collated to form guidelines addressing its diagnosis and management.1 This is appropriate as PE is common, and was observed in 18% of all autopsies in a recent Swedish study,1 with an incidence in hospital patients of 0.4%. It has a mortality rate of 7–11%,1 killing up to 10% of patients within the…
View more
Author(s):
Dan Gaiţă
,
Svetlana Moşteoru
,
Laurence S Sperling
Added:
3 years ago
The increasing worldwide prevalence of diabetes mellitus (DM) means almost 360 million people are suffering from this disease (in 2011) and it is estimated to reach 552 million people by 2030.1 The latest European Action on Secondary Prevention by Intervention to Reduce Events (EuroASPIRE) study (2013) has revealed that the mean prevalence of DM in European patients with coronary artery disease …
View more
Author(s):
Rodrigo Alonso
,
Leopoldo Perez de Isla
,
Ovidio Muñiz-Grijalvo
,
et al
Added:
3 years ago
Familial hypercholesterolaemia (FH) is the genetic disorder most commonly associated with elevated LDL cholesterol (LDL-C) levels from birth and with premature atherosclerotic cardiovascular disease (ASCVD).1 It is caused by mutations in genes related to the clearance of LDLs such as LDL receptor (LDLR), apolipoprotein B-100 (APOB) and proprotein convertase subtilisin/kexin type 9 (PCSK9).2 The…
View more
Author(s):
Haider Aldiwani
,
Suzan Mahdai
,
Ghaith Alhatemi
,
et al
Added:
2 years ago
Author(s):
Harold Bays
Added:
1 year ago
ACC.23/WCC — Dr Harold Bays, Science Officer for the Obesity Medicine Association, member of the Board of Trustees of the Obesity Medicine Association, and member of the Board of Directors of the American Society of Preventive Cardiology joins us to talk about obesity management and the emergence of anti-obesity drugs and multidisciplinary team approach.
Discussion Points:
Unmet Needs in the…
View more
Author(s):
Gaetano Antonio Lanza
,
Hiroaki Shimokawa
Added:
10 months ago
Author(s):
Kevin Cheng
,
Paul Sainsbury
,
Michael Fisher
,
et al
Added:
3 years ago
Refractory angina (RA) is conventionally defined as a chronic condition (≥3 months in duration) characterised by angina in the setting of coronary artery disease (CAD), which cannot be controlled by a combination of optimal medical therapy, angioplasty or bypass surgery, and where reversible myocardial ischaemia has been clinically established to be the cause of the symptoms.1
In clinical…
View more
Author(s):
Kashish Goel
,
Colin M Barker
,
JoAnn Lindenfeld
Added:
3 years ago
Heart failure (HF) is a growing epidemic, with an estimated 6.2 million adults (≥20 years) affected between 2013 and 2016 in the US.1 The prevalence is increasing and is expected to reach 8 million by 2030.1 Mitral regurgitation (MR) is common in HF patients, especially in those with ischaemia, left ventricular (LV) dysfunction or dilated cardiomyopathy. MR in the absence of structural…
View more
Author(s):
Frédéric Michard
Added:
3 years ago
Volume expansion is one of the most common therapeutic procedures in intensive care units (ICUs). There is no doubt that in some cases (e.g. hemorrhage or severe diarrhea) care-givers can reasonably rely on clinical examination to identify patients who will benefit from fluid loading. However, in more complex—but not uncommon—situations (e.g. septic shock), both clinical examination and…
View more
Author(s):
Michel Burnier
Added:
3 years ago
In 2007, the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) published their guidelines for the management of arterial hypertension.1 These guidelines covered in detail all aspects of the management of hypertensive patients, from the diagnosis and detection of early subclinical organ damage to the discussion of the various therapeutic strategies in essential…
View more